KRISTINA PARSONS: Open Payments
NPI 1336338565 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,990 in 89 payments from 17 companies in 2025. Trend: 2023 $1,611 · 2024 $1,252 · 2025 $1,990
Food & beverage: $1,890Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $347 |
| GENZYME CORPORATION | 10 | $241 |
| UCB, Inc. | 10 | $227 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $204 |
| Galderma Laboratories, L.P. | 10 | $138 |
| Amgen Inc. | 9 | $135 |
| ABBVIE INC. | 6 | $125 |
| Regeneron Healthcare Solutions, Inc. | 3 | $98 |
| Arcutis Biotherapeutics, Inc. | 4 | $72 |
| Janssen Biotech, Inc. | 4 | $70 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, OTEZLA, COSENTYX, SKYRIZI, Rhapsido, ILUMYA.
Industry payments across TX — which companies pay providers there.
